For example, the ROI can be selected in immune-depleted areas or immune-enriched areas based on CD45 expression in the tissue sample; in tumor invasive margin vs. central tumor areas based on spatial tumor location; or tumor tissue vs. normal-appearing tissue based on the morphological characteristics of the tissue sample. Here, PTPRC is linked to neoplasm.